2010;122:1612 20. 52. Shah SA, Shapiro RJ, Mehta R, et al. Impact of enhanced external counterpulsation on Canadian Cardiovascular Society angina class in patients with chronic stable angina: a meta-analysis. Pharmacotherapy. 2010;30:639 45. 53. Stys TP, Lawson WE, Hui JCK, et al. Effects of enhanced external coun- terpulsation on stress radionuclide coronary perfusion and exercise capac- ity in chronic stable angina pectoris. Am J Cardiol. 2002;89:822 4. 54. Barsness G, Feldman AM, Holmes DRJ, et al. The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin Cardiol. 2001;24:435 42. 55. Wu E, M rtensson J, Brostr m A. Enhanced external counterpulsation in patients with refractory angina pectoris: a pilot study with six months follow-up regarding physical capacity and health-related quality of life. Eur J Cardiovasc Nurs. 2013;12:437 45. 56. McKenna C, McDaid C, Suekarran S, et al. Enhanced external counter- pulsation for the treatment of stable angina and heart failure: a system- atic review and economic analysis. Health Technol Assess. 2009;13:iii-iv, ix-xi, 1 90. 57. Amin F, Al Hajeri A., Civelek B, et al. Enhanced external counter- pulsation for chronic angina pectoris. Cochrane Database Syst Rev. 2010;CD007219. 58. Sorajja P, Chareonthaitawee P, Rajagopalan N, et al. Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting. Circulation. 2005;112:I311 6. 59. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997;96:1761 9. 60. Banning AP, Westaby S, Morice MC, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: compari- son of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol. 2010;55:1067 75. 61. Hoffman SN, TenBrook JA, Wolf MP, et al. 